Inhibition of drug-induced seizure development in both zebrafish and mouse models by a synthetic nanoreceptor

被引:25
|
作者
Huang, Qiaoxian [1 ]
Kuok, Kit Ieng [1 ]
Zhang, Xiangjun [1 ,2 ]
Yue, Ludan [1 ]
Lee, Simon M. Y. [1 ]
Zhang, Jianxiang [2 ]
Wang, Ruibing [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China
[2] Third Mil Med Univ, Coll Pharm, Dept Pharmaceut, Chongqing 400038, Peoples R China
关键词
NEUROMUSCULAR BLOCK; GENERAL-ANESTHESIA; IN-VIVO; CHEMISTRY; EPILEPSY; HOST;
D O I
10.1039/c8nr02041h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A synthetic nanoreceptor, cucurbit[7]uril (CB[7]), fully encapsulated pentylenetetrazol (PTZ), a seizure-inducing model drug. As a consequence of the encapsulation, the development of PTZ induced convulsion behaviors in both larval zebrafish and mouse models were dramatically alleviated, suggesting that CB[7] holds great neuroprotection potential against neurotoxic drugs for clinical applications.
引用
收藏
页码:10333 / 10336
页数:5
相关论文
共 35 条
  • [1] Development of an alternative zebrafish model for drug-induced intestinal toxicity
    Ryu, Bokyeong
    Kim, C-Yoon
    Oh, Hanseul
    Kim, Ukjin
    Kim, Jin
    Jung, Cho-Rok
    Lee, Byoung-Hee
    Lee, Seungki
    Chang, Seo-Na
    Lee, Ji Min
    Chung, Hyung-Min
    Park, Jae-Hak
    JOURNAL OF APPLIED TOXICOLOGY, 2018, 38 (02) : 259 - 273
  • [2] Tanshinone IIA Exhibits Anticonvulsant Activity in Zebrafish and Mouse Seizure Models
    Buenafe, Olivia Erin
    Orellana-Paucar, Adriana
    Maes, Jan
    Huang, Hao
    Ying, Xuhui
    De Borggraeve, Wim
    Crawford, Alexander D.
    Luyten, Walter
    Esguerra, Camila V.
    de Witte, Peter
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (11): : 1479 - 1487
  • [3] A FATAL ASSOCIATION BETWEEN A SEIZURE AND DRUG-INDUCED PARKINSONISM
    LICHTIGFELD, FJ
    GILLMAN, MA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (04) : 237 - 238
  • [4] A rapid assessment for predicting drug-induced hepatotoxicity using zebrafish
    Zhang, Yun
    Han, Liwen
    He, Qiuxia
    Chen, Weiyun
    Sun, Chen
    Wang, Xue
    Chen, Xiqiang
    Wang, Rongchun
    Hsiao, Chung-Der
    Liu, Kechun
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 84 : 102 - 110
  • [5] Which drug-induced side effects would be tolerated in the prospect of seizure control?
    Witt, Juri-Alexander
    Elger, Christian E.
    Helmstaedter, Christoph
    EPILEPSY & BEHAVIOR, 2013, 29 (01) : 141 - 143
  • [6] Tolerance to seizure induced by kainic acid is produced in a specific period of zebrafish development
    Menezes, Fabiano Peres
    Rico, Eduardo Pacheco
    Da Silva, Rosane Souza
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 55 : 109 - 112
  • [7] Virtual screening and zebrafish models in tandem, for drug discovery and development
    Hernandez-Silva, David
    Alcaraz-Perez, Francisca
    Perez-Sanchez, Horacio
    Luisa Cayuela, Maria
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (08) : 903 - 915
  • [8] Seizure-induced Torsades de pointes:In a canine drug-induced long-QT1 model
    van der Linde, Henk
    Kreir, Mohamed
    Teisman, Ard
    Gallacher, David J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [9] Do in vitro assays in rat primary neurons predict drug-induced seizure liability in humans?
    Kreir, M.
    Van Deuren, B.
    Versweyveld, S.
    De Bondt, A.
    Van den Wyngaert, I.
    Van der Linde, H.
    Lu, H. R.
    Teuns, G.
    Gallacher, D. J.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 346 : 45 - 57
  • [10] Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
    Carr, Daniel F.
    Ayehunie, Seyoum
    Davies, Andrea
    Duckworth, Carrie A.
    French, Stephanie
    Hall, Neil
    Hussain, Syed
    Mellor, Howard R.
    Norris, Alan
    Park, B. Kevin
    Penrose, Alexander
    Pritchard, D. Mark
    Probert, Chris S.
    Ramaiah, Shashi
    Sadler, Claire
    Schmitt, Michael
    Shaw, Alison
    Sidaway, James E.
    Vries, Robert G.
    Wagoner, Matthew
    Pirmohamed, Munir
    PHARMACOLOGY & THERAPEUTICS, 2017, 172 : 181 - 194